Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsDigestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, intestinal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 1 / Phase 22026-04-22NCT07020221

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Verastem, Inc.24

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Cedars-Sinai Medical CenterLos AngelesUnited States392
Huntsman Cancer InstituteSalt Lake CityUnited States107
Johns Hopkins UniversityBaltimoreUnited States150
Laura & Isaac Perlmutter Cancer Center At NYU LangoneNew YorkUnited States2
Massachusetts General HospitalBostonUnited States1015
MD Anderson Cancer CenterHoustonUnited States589
Peninsula and Southeast OncologyFrankstonAustralia3
Scri Oncology PartnersNashvilleUnited States156
Univ of Pennsylvania, Abramson Cancer CenterPhiladelphiaUnited States1
University of MichiganAnn ArborUnited States538
University of VirginiaCharlottesvilleUnited States122
Virginia Cancer SpecialistsFairfaxUnited States109
Virginia Mason Medical CenterSeattleUnited States111
Washington University School of MedicineSt LouisUnited States895